Emergent BioSolutions (EBS) Tops Q1 EPS by 23c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Emergent BioSolutions (EBS) Tops Q1 EPS by 23c

Emergent BioSolutions Reports First Quarter 2016 Financial Results

May 5, 2016 4:18 PM EDT

Q1 2016 financial performance in line with guidanceCDC notifies the Company of its intent to award a follow-on BioThrax procurement contract on October 1, 2016In transitioning to the follow-on contract, the Company is temporarily postponing its 2016 financial guidance until CDC confirms level of Q2 and Q3 BioThrax procurement

GAITHERSBURG, Md., May 05, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter ended March 31, 2016.

Q1 2016 FINANCIAL HIGHLIGHTS

Total revenues of $111.0 millionGAAP net income of $4.0 million, or $0.10 per diluted... More